9th Annual Biomarkers Congress
Controversies in Vaccination in Adults (CoVAC)
Leonardo Royal Hotel Berlin
Otto-Braun-Strasse 90
Leonardo Royal Hotel Berlin, Berlin
http://www.comtecmed.com/covacc/2011/program.aspx
http://www.comtecmed.com/covacc/2011/program.aspx

Schedule of Presentations:

Thursday, January 27, 2011
Friday, January 28, 2011
08:30:00 Opening Ceremony by Conference Chairmen H. Lode
08:40:00 Opening Address
08:40:00 Session 1 | Pneumococcal Vaccine (I)
08:45:00 Overview of pneumococcal vaccines beneficial effects K. Klugman
08:55:00 Debate: Is hyporesponsiveness with polysaccharide vaccines a problem? R. R. Reinert, David Goldblatt
09:25:00 Discussion
09:30:00 Debate: Are the effects of polysaccharide vaccines long lasting? David Fedson, J. Garau
10:05:00 Discussion
10:15:00 Coffee Break
10:45:00 Session 2 | Pneumococcal Vaccine (II)
11:00:00 Debate: Did the last Influenza (H1N1) epidemic provide answers to the dilemmas or add to the confusion on the impact of pneumococcal vaccination? Tobias Welte, K. Klugman
11:15:00 Discussion
11:30:00 Round Table Discussion | Questions G. Regev-Yochay
12:30:00 Lunch Break
13:30:00 Session 3 | H1N1 pandemic: Much Ado About Nothing?
13:45:00 Medical talk: Influenza pandemics: Do we still need to prepare?
14:00:00 Governmental talk: (Pre-)pandemic preparedness & coordination i n Germany: Status Quo & future perspectives. A. Wirtz
14:15:00 Media/Public opinion: Challenges for implementation of the pandemic vaccination programme: the Swedish experience
15:00:00 Coffee Break
15:15:00 Session 4 | Seasonal Flu Vaccine Tobias Welte
15:30:00 Debate Is the vaccine efficacious in changing overall morbidity and mortality? Ellis Rubinstein, Mathias Pletz
15:45:00 Discussion
16:00:00 Round Table Discussion | Questions W. P. Glezen, R. Arnon
16:30:00 Session 5 | Pseudomonas Aeruginosa
16:35:00 Clinical importance of Pseudomonas Aeruginosa infections N. Höiby
16:40:00 Debate: Will we ever have an effective Pseudomonas Aeruginosa vaccine? G. Doering
17:10:00 Discussion
17:25:00 Round Table Discussion | Questions
Saturday, January 29, 2011
06:00:00 Session 15 | Question J. Grabenstein
08:30:00 Session 6 | Plenary Session
08:35:00 Staphylococcal Vaccine
08:40:00 Overview J. Lee
08:45:00 Debate: Is there a future for an effective staphylococcal vaccine?
09:10:00 Discussion
09:25:00 Round Table Discussion | Questions S. Foster
09:45:00 Coffee Break
10:15:00 Session 7 | VZV Vaccine
10:15:00 Session 12 | Tuberculosis Vaccine
10:20:00 Session 7 | Debate: Is there a need for HZV vaccine in the elderly – that is only 50-60% efficacious? Ethan Rubinstein, P. Wutzler
10:20:00 Session 12 | Overview: Tb burden worldwide
10:25:00 Session 7 | Overview Tamar Juven-Gershon
10:25:00 Session 12 | Debate: Will an effective and affordable Tb vaccine be available in the near future? H. Rieder
10:55:00 Session 7 | Discussion
11:10:00 Session 12 | Discussion
11:10:00 Session 7 | Round Table Discussion Questions H. Lode
11:20:00 Session 12 | Round Table Discussion Questions H. Bercovier, R. Loddenkemper
11:45:00 Session 13 | HPV Vaccine
11:45:00 Session 8 | Meningococcal Vaccine
11:50:00 Session 8 | Overview: Tb burden worldwide R. Rappuoli
11:50:00 Session 8 | Debate: Has the vaccine changed the global epidemiology of the meningococcal disease? J. Garau
11:50:00 Session 13 | Overview of HPV: changes in global epidemiology
12:00:00 Session 13 | Shall we extend the indications of HPV vaccination? Elmar Joura
12:15:00 Session 13 | Discussion
12:25:00 Session 8 | Discussion
12:30:00 Session 13 | Questions H. Ikenberg
12:35:00 Session 8 | Round Table Discussion Questions J. Garau
13:00:00 Lunch Break
14:00:00 Session 9 | The Influenza Paradox
14:15:00 Session 9 | Debate: Influenza disease burden on the society is well established, even if not widely acknowledged. Should universal influenza vaccine policy be implemented according to the common guidelines?
14:20:00 Session 9 | Pro: vaccination reduces the "disease burden" and save lives. Influenza is a preventable disease and should be prevented!
14:40:00 Session 9 | Discussion
14:50:00 Session 9 | How disabling can influenza be. Can vaccination prevent this and to what extent? Janet Mcelhaney
15:15:00 Session 9 | Should national policy guidelines be implemented regardless of physician own views?
16:00:00 Session 10 | H1N1 Swine Flu Vaccine
16:00:00 Session 14 | Anti-Smoking Vaccine
16:05:00 Session 10 | Overview of the H1N1 vaccine beneficial effects P. Wutzler
16:05:00 Session 14 | Overview H. Lode
16:10:00 Session 14 | Debate: Will a vaccine be successful? Jacques Cornuz
16:10:00 Session 10 | Debate Did the H1N1 vaccine change the epidemiology of the recent H1N1 pandemic? R. Rappuoli
16:25:00 Session 9 | Con: The evidence on vaccination's benefits are not strong enough and therefore the risk benefit ratio may be questionable
16:35:00 Session 10 | Discussion
16:40:00 Session 14 | Discussion
16:40:00 Session 10 | Round Table Discussion Questions H. J. Schmitt
16:55:00 Session 14 | Round Table Discussion Questions
17:15:00 Session 15 | Anthrax and Smallpox Vaccines
17:15:00 Session 11 | Clostridium Difficile Vaccine
17:20:00 Session 11 | Overview H. Bercovier
17:20:00 Session 15 | Overview
17:25:00 Session 11 | Debate: Will it work? For whom? Arne Rodloff, D. Gerding
17:25:00 Session 15 | Next Generation Anthrax Vaccines
17:40:00 Session 15 | Discussion
17:50:00 Session 11 | Discussion
18:00:00 Session 11 | Round Table Discussion Questions Petra Gastmeier
Sunday, January 30, 2011
09:00:00 Session 16 | H5N1 Bird Flu Vaccine
09:05:00 Session 16 | Introduction H. W Doerr
09:10:00 Session 16 | Does Bird Flu constitute an eminent global threat?
09:45:00 Session 16 | Discussion
10:30:00 Session 17 | Future of Vaccination H. Lode
10:30:00 Session 17 | Basic sciences R. Arnon
11:00:00 Session 17 | Clinical aspects: VZV Vaccines
11:30:00 Session 17 | Ethical aspects B. Velan
12:00:00 Summary H. Lode, Ellis Rubinstein
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.